Products - Minapharm Pharmaceuticals

Reiferon Retard^® Ampoules

Ingredient Pegylated Hansenula-derived recombinant interferon alfa-2a 160 µg. Multinational Partner Rhein Biotech Disease Category Hepatology & Gastroenterology

Reiferon Retard is the 3rd Worldwide Novel Pegylated Hansenula-derived Recombinant Interferon alfa-2a for subcutaneous administration.

Thrombexx^® Ampoules

Ingredient 15 mg of Recombinant Hirudin Multinational Partner Rhein Biotech Disease Category Hematoma & Thrombosis

Thrombexx^® Cream

Ingredient Topical r-hirudin 1120 I.U. Multinational Partner Rhein Biotech Disease Category Hematoma & Thrombosis

Thrombexx® cream: As an extension to Rhein-Minapharm's r-Hirudin portfolio, Thrombexx® 1120 I.U cream is introduced for the treatment of hematoma, thrombophlebitis and shunt thrombosis prophylaxis.

Thrombexx^® Gel

Ingredient Topical r-hirudin 1120 I.U. Multinational Partner Rhein Biotech Disease Category Hematoma & Thrombosis

Thrombexx® Gel: As an extension to Rhein-Minapharm's r-Hirudin portfolio, Thrombexx® 1120 I.U gel is introduced for the treatment of hematoma, thrombophlebitis and shunt thrombosis prophylaxis.

Corporate News Read More »

Scientific News Read More »

The Infertile Couples…. (The road Map) - Meet the Expert No. 288

Minapharm organized this event in collaboration with Repro IVF Center
ProBioGen - MINAPHARM - OM Pharma - “Biological Technologies; Managing Fertility & Prophylaxis of Recurrent UTIs” in Berlin

The Therapeutic focus of Minapharm in the field of gynecology
Latest Updates in the Management of Mixed Infection - Meet the Expert No. 275

Latest updates in diagnosis and treatment of diverticular disease of

Latest Products Read More »

MINAPHARM announces the launch of the first minoxidil 5% foam in Egypt, Hair Plus Back Topical foam, prescribed in various types of alopecia and hair loss.

Newsletter Sign-up

Stay connected, subscribe to our newsletter for news and updates.

Office Address

Address: El-Bardissi St., 2T Takseem Asmaa Fahmy St., Heliopolis, Cairo - Egypt.

Phone: (+202) 2414-3170/1/2/3/4/5

Fax: (+202) 2414-3179

Email: mailbox@minapharm.com

Product List

Reiferon Retard^® Ampoules

Thrombexx^® Ampoules

Thrombexx^® Cream

Thrombexx^® Gel

Filtered Alphabetically

Search by Disease Category:

Search by Products Lines:

Corporate News Read More »

Our Subsidiary ProBioGen celebrates the 20th anniversary: €20 million investment in Mammalian Manufacturing Expansion

VTU Technology, Austria and MINAPHARM Pharmaceuticals S.A.E., Egypt enter into development and license agreement

MINAPHARM Pharmaceuticals acquires majority stake in ProBioGen – Dr. Wieland Wolf appointed new CEO

Scientific News Read More »

The Infertile Couples…. (The road Map) - Meet the Expert No. 288

ProBioGen - MINAPHARM - OM Pharma - “Biological Technologies; Managing Fertility & Prophylaxis of Recurrent UTIs” in Berlin

Latest Updates in the Management of Mixed Infection - Meet the Expert No. 275

Latest Products Read More »

Newsletter Sign-up

Office Address

Social Media

Product List

Reiferon Retard® Ampoules

Thrombexx® Ampoules

Thrombexx® Cream

Thrombexx® Gel

Filtered Alphabetically

Search by Disease Category:

Search by Products Lines:

Corporate News Read More »

Our Subsidiary ProBioGen celebrates the 20th anniversary: €20 million investment in Mammalian Manufacturing Expansion

VTU Technology, Austria and MINAPHARM Pharmaceuticals S.A.E., Egypt enter into development and license agreement

MINAPHARM Pharmaceuticals acquires majority stake in ProBioGen – Dr. Wieland Wolf appointed new CEO

Scientific News Read More »

The Infertile Couples…. (The road Map) - Meet the Expert No. 288

ProBioGen - MINAPHARM - OM Pharma - “Biological Technologies; Managing Fertility & Prophylaxis of Recurrent UTIs” in Berlin

Latest Updates in the Management of Mixed Infection - Meet the Expert No. 275

Latest Products Read More »

Newsletter Sign-up

Office Address

Social Media

Reiferon Retard^® Ampoules

Thrombexx^® Ampoules

Thrombexx^® Cream

Thrombexx^® Gel